A series of ruthenium(II)-chelating poly(heteroaryleneethynylene)s were synthesized by the palladium-catalyzed cross-coupling polycondensation of diethynylbenzenes and dibromobipyridine−Ru(II) chelates. The grafting of different alkoxy side chains including n -butoxy, (2-ethylhexyl)oxy, and n -octadecyloxy in the diethynylbenzene compounds enhances the solubility and processability of the new polymers. The same effect is attainable by tert -butyl substituents in the 2,2‘-bipyridine ligands. The UV/vis absorption showed a considerable red shift of the λ max from poly{bis(2,2‘-bipyridine)-[2,2‘-bipyridine-5,5‘-diylethynylene-(2,5-dialkoxy)ethylene]ruthenium(II) bis(hexafluorophosphate)} ( 5 ) to the 4,4‘-diylethynylene isomers 6, suggesting an increase in the electronic delocalization between the backbone and ruthenium(II) chelate. The polymers are good photoconducting materials ( I Ph = 3.7 × 10 -12 A at 18 000 cm -1 ), exhibiting an oxidation potential of 1.24 V vs SCE. The polymers are thermostable and exhibit a good solubility in acetone, DMF, DMSO, acetonitrile, and cyclohexanone. Last, an improved method of molecular weight determination by GPC was devised.
No takes yet. Share an insight, caveat, or question.
Pautzsch et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: